(b)(4).B.Braun medical, inc.(importer) is submitting this report on behalf of b.Braun (b)(4).This report has been identified as b.Braun (b)(4) internal report # (b)(4).We received 3 used and empty easypump ii lt 270-54-s without packaging.The received samples were taken to a visual inspection.In as-received condition the white clamp was missing at the 3 received samples.The original wing cap was not handed over by the customer, the patient connector was closed with a combi stopper at the 3 received samples.After opening the top cap we detected crystallized drug residues and residues of solution (liquid) at the filling port (lli-cone) and at the patient connector of the 3 received samples.Afterwards the 3 samples were filled up to the nominal volume of 270 ml with nacl 0.9 % and a functional test respectively a leak test was carried out.After opening the patient connector and waiting for 60 minutes the 3 pumps worked (solution was running).Furthermore we tested the flow rate of the 3 received samples.(b)(6).2 inspected samples are not within our specifications.The cause for the too fast flow at 2 received samples could not be find out.We have informed our manufacturer accordingly.A follow-up report will be provided after the statement is available.Reviewed the device history record and no abnormalities found during in process and final control inspection.
|
(b)(4).Statement from manufacturer: according to bbm preliminary investigation, all complaint samples were flowing.However, flow rate of 2 returned samples were not within specification.As the complaint samples were contaminated with cytotoxic drug, further investigation is not possible.Therefore, the complaint is considered as not judgeable.However, flow rate deviation is a known issue and addressed in capa (b)(4).Blockage issue is addressed in capa (b)(4).Cause: failure in production process.
|